Services

  1. Viral Vector Contract Testing, Development, & Manufacturing Services (CTDMO) 9/7/2023

    ADVANCING CELL AND GENE THERAPIES FOR PATIENTS

    Millipore® CTDMO Services delivers expertise and flexible solutions for viral vector development and manufacturing to advance cell and gene therapies from preclinical through commercial production.

  2. Apollo™ 8/18/2023

    Apollo™ is an innovative platform that empowers you with real-time access to study data, milestones, documents, and program planning tools.

  3. SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be 8/4/2023

    Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  4. SUREtechnology Platform™ 8/4/2023

    Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.

  5. Drug Substance Services 7/27/2023

    Examine our drug product manufacturing capabilities and how our skilled scientists work with customers to build a chemical in a cost-effective and timely manner throughout the clinical development process.

  6. AGCellerate For mAbs 6/29/2023

    AGC Biologics has released a new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers. AGCellerate offers guaranteed amounts at fixed timelines and costs –accelerating projects through development and into clinical phases.

  7. Safety Assessment Services 6/20/2023

    A full range of in vivo and in vitro testing services that can be customized for your project’s needs to expedite preclinical development while maintaining a high quality standard.

  8. One Step 6/20/2023

    Make strides with a tailored, comprehensive suite of discovery and development services to rapidly progress your project and reduce time to market.

  9. Protein L Resin For Affinity Capture 5/3/2023

    MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.

  10. Bionanoparticle Technology 4/24/2023

    Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.